Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortPowerful red chemotherapy for breast cancer, lymphoma and sarcoma.Chemotherapy that also treats severe autoimmune disease.
Body systemCancerCancer
Drug classAnthracyclinesAlkylating agents
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesBreast cancer, Lymphomas, Leukaemias, Sarcomas, Many childhood cancersLymphoma, Breast cancer, Leukaemia, Severe lupus and vasculitis, Before stem cell transplants
How it worksDamages cancer cell DNA so they can't divide.Damages DNA so dividing cells die.
Starts working——
Half-life——
Typical adult doseDose by body surface area per cycle; lifetime maximum around 450–550 mg/m².Varies widely by condition and regimen.
FormsIV infusion, Liposomal infusionIV infusion, Tablet
Common side effectsHair loss, Nausea, Mouth sores, Red urine (1–2 days), Low blood countsNausea, Hair loss, Low blood counts
Serious side effectsHeart damage (dose-related, can appear years later), Severe tissue damage if it leaks from the vein, Secondary leukaemia (rare)Bleeding from the bladder, Infertility, Secondary cancers, Infections
Don't take if——
Alcohol——
PregnancyUsually avoidedAvoided in the first trimester; sometimes given later under specialists.Usually avoidedCauses birth defects.
Breastfeeding——
In use since19741959
Brand namesUnited States: Adriamycin, DoxilUnited Kingdom: CaelyxIndia: Adriamycin, LipodoxUnited States: Cytoxan (historic)United Kingdom: CyclophosphamideIndia: Endoxan, Cyclomide
Legal status——
ATC codeL01DB01L01AA01

Taken together

  • ModerateDoxorubicin + Cyclophosphamide: Added bone marrow suppression

    Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.

Open in the interaction checker